JPRN-UMIN000008585Recruiting未知
A pilot study to evaluate the efficacy of 3 doses of L-carnitine supplementation in chronic kidney disease patients with complications caused by carnitine deficiency - "CENTRAL"
Yokohama City Minato Red Cross Hospital0 sites150 target enrollmentStarted: August 1, 2012Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Enrollment
- 150
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1)history of allergy against this drug 2)ability of oral administration 3)alcoholic or drug abuse 4)cancer 5)patients who are judged to be inappropriate to this study
Investigators
Similar Trials
Active, not recruiting
Phase 1
A study to test the effectiveness and safety of bacteria called Bifidobacterium breve in patients with COVID-19 infectionsSymptoms of Covid-19 infectionMedDRA version: 20.0Level: LLTClassification code 10061986Term: SARSSystem Organ Class: 100000004862EUCTR2020-001597-30-GB4D pharma plc90
Active, not recruiting
Phase 1
First study to test the validity of the treatment of the disease called idiopathic pulmonary fibrosis, which causes inflammation and fibrosis (scarring) of the lung tissue, with a drug called cotrimoxazole.Ambulatory patients, men and women, with well-established diagnosis of idiopathic pulmonary fibrosis.MedDRA version: 14.1Level: PTClassification code 10021240Term: Idiopathic pulmonary fibrosisSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2012-005409-38-ESFundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)56
Active, not recruiting
Phase 1
Clinical trial of a new protocol of lung maturation by administration of corticoids in twin pregnancy patients with threatened preterm birth treated by Atosiban : administration of 3 doses of betamethasone (12 mg) in 18 hours apart, rather than 2 doses of betamethasone (12 mg) in 24 hours apart as used usually, to decrease the risk of respiratory distress syndrome at the newborn childrePremature delivery in twin pregnanciesMedDRA version: 19.1Level: LLTClassification code 10028244Term: Multiple pregnancy affecting fetus or newbornSystem Organ Class: 100000004868MedDRA version: 19.1Level: LLTClassification code 10036564Term: Pregnancy multipleSystem Organ Class: 100000004868EUCTR2016-003603-61-BE50
Completed
Phase 2
Comparing the effect of three-doses of dexamethasone with a single-dose in reducing intraoperative bleeding, blood pressure, operation time, edema and ecchymosis induced by rhinoplastyPlastic Surgery.Procedures for purposes other than remedying health stateIRCT2014011316195N1Deputy of Research and Technology of Babol University of Medical Sciences100
Completed
Not Applicable
euprolide acetate 3 month depot medicine use in advance prostate cancerCTRI/2021/07/034710Bharat Serums and Vaccines ltd8